510(k) device
SCOUT MD Surgical Guidance System
Merit Medical System, Inc. · Marker, Radiographic, Implantable (NEU, Class II) · First FDA decision Feb 12, 2024, newest Feb 12, 2024Breast cancer
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
1
Naming "SCOUT MD"
MAUDE reports
5
Brand "SCOUT MD", since 2015
PubMed studies
2
Mentioning "SCOUT MD"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SCOUT MD Surgical Guidance System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- SCOUT MD Surgical Guidance SystemBreakthrough510(k)
K231468 · Decided Feb 12, 2024 · 266 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SCOUT MD", any status and sponsor, newest update first.
H. Lee Moffitt Cancer Center and Research InstituteAcademic, hospital or other
NCT07686250 · 37 participants (planned) · Start Jul 29, 2026 · Primary completion Jul 2028
Device: SAVI Scout MD system · For: Breast Cancer
Sites: Tampa, Florida
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SCOUT MD", and for the whole product code for context.
This brand
5 reports: 4 malfunction, 0 injury, 0 death
Whole product code NEU
1,678 reports: 518 malfunction, 1,149 injury, 1 death
Newest reports for this brand
- SCOUT MD¿Malfunction
1721504-2026-00046 · Received Oct 27, 2026 · Event dated Sep 21, 2026
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Premature Activation
Patient problem as coded: Insufficient Information
- SCOUT MD¿Malfunction
1721504-2026-00443 · Received Sep 25, 2026 · Event dated Jul 8, 2026
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Self-Activation or Keying
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SCOUT MD¿Malfunction
1721504-2026-00419 · Received Aug 24, 2026 · Event dated Jul 27, 2026
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Fail-Safe Did Not Operate
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SCOUT MD"[tiab]. The summary above synthesizes these.
- Case Report: SCOUT MDࡊ four reflector technology-enhancing accuracy in breast lesion isolation.
LaRussa A, Caputo S, Sadeghi A, et al. · Front Surg · 2025Case Reports
- SCOUT MDࡊ for breast and axillary localisation: a narrative review toward a single radar-based platform.
Wazir U, Mokbel K · Gland Surg · 2026Review
Other devices of this type
Also filed under product code NEU.
- HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. · 510(k) 2022
- MOLLI 2 SystemMolli Surgical, Inc. · 510(k) 2024
- HydroMARK Plus Breast Biopsy Site Marker (Dragonfly Shape)Devicor Medical Products, Inc. · 510(k) 2026
- UltraCor Twirl Breast Tissue MarkerBard Peripheral Vascular, Inc. · 510(k) 2025
- RFID Localization SystemHealth Beacons, Inc. · 510(k) 2020
- Cianna Medical SAVI Scout Reflector and SAVI Scout SystemCianna Medical, Inc. · 510(k) 2018
- Beacon Tissue Marker (SE)Scion Medical Technologies, LLC · 510(k) 2015
- Biopsy Sciences, Inc. Hydromark Brest Biosy Site MarkerBiopsy Sciences, LLC · 510(k) 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.